Fairfax Financial Holdings’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-139,687	Closed	-$472K	–	31
2024 Q4	$472K	Sell	139,687 -31,250	-18%	-$101K	0.03%	30
2024 Q3	$485K	Hold	170,937	–	–	0.04%	31
2024 Q2	$383K	Buy	170,937 +19,542	+13%	+$39.4K	0.03%	37
2024 Q1	$333K	Hold	151,395	–	–	0.03%	42
2023 Q4	$356K	Hold	151,395	–	–	0.02%	57
2023 Q3	$282K	Hold	151,395	–	–	0.02%	60
2023 Q2	$395K	Hold	151,395	–	–	0.02%	60
2023 Q1	$245K	Hold	151,395	–	–	0.01%	64
2022 Q4	$200K	Hold	151,395	–	–	0.01%	73
2022 Q3	$236K	Hold	151,395	–	–	0.01%	69
2022 Q2	$232K	Hold	151,395	–	–	0.01%	67
2022 Q1	$388K	Hold	151,395	–	–	0.01%	65
2021 Q4	$441K	Buy	+151,395	New	+$327K	0.01%	60